Techniques for studying the pharmacodynamic effects of cardiac glycosides on patients' own erythrocytes during glycoside therapy
- 1 December 1981
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 59 (24) , 1323-1332
- https://doi.org/10.1007/bf01720552
Abstract
We have measured the effects of digoxin on the cation transport mechanisms of patients' erythrocytes during treatment with digoxin for atrial fibrillation and cardiac failure in sinus rhythm. The results show that during short-term treatment with digoxin there is occupation of erythrocytic cardiac glycoside receptors by digoxin with resultant inhibition of active cation transport. These effects correlate well with the patients' clinical responses to treatment. During long-term treatment, however, these effects are not seen, suggesting that there is pharmacological tolerance to the effects of digoxin. The clinical implications of these results are discussed. Die Effekte von Digoxin auf die Mechanismen des Kationentransportes wurden an den Erythrozyten der Patienten untersucht. Die Studien wurden während Digoxinbehandlung bei Vorhofflimmern und bei Herzinsuffizienz mit Sinusrhythmus durchgeführt. Die Resultate zeigen, daß während kurzzeitiger Behandlung mit Digoxin die Rezeptoren für Herzglykoside an den Erythrozyten besetzt werden, woraus eine Hemmung des aktiven Kationentransportes resultiert. Diese Wirkungen zeigen eine gute Korrelation mit dem klinischen Erfolg der Behandlung. Während Langzeitbehandlung lassen sich diese Wirkungen jedoch nicht nachweisen. Dieser Befund legt nahe, daß dabei eine pharmakologische Toleranz gegenüber den Digoxinwirkungen eintritt. Die klinische Bedeutung dieser Befunde wird diskutiert.Keywords
This publication has 10 references indexed in Scilit:
- THE USE OF COLOR-VISION MEASUREMENT IN THE DIAGNOSIS OF DIGOXIN TOXICITY1980
- The acute changes seen in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy are not found during chronic therapy: pharmacological and therPublished by Wiley ,1979
- Changes in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients receiving digoxin during the early phases of treatment of cardiac failure in regular rhythm and of atrial fibrillation.Published by Wiley ,1979
- The characteristics of the binding of 12‐alpha‐[3H]‐digoxin to the membranes of intact human erythrocytes: relevance to digoxin therapy.British Journal of Clinical Pharmacology, 1979
- MONITORING DIGOXIN THERAPY - USE OF PLASMA DIGOXIN CONCENTRATION MEASUREMENTS IN DIAGNOSIS OF DIGOXIN TOXICITY1978
- Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response.Published by Wiley ,1977
- The Serum Digitalis Concentration — Does It Diagnose Digitalis Toxicity?New England Journal of Medicine, 1976
- Quantitative aspects of ouabain binding to human erythrocyte and cardiac membranes.The Journal of Physiology, 1975
- The sodium-potassium adenosine triphosphatase: pharmacological, physiological and biochemical aspects.1975